Correlation Between Inozyme Pharma and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Century Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Century Therapeutics.
Diversification Opportunities for Inozyme Pharma and Century Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Century is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Century Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Century Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Century Therapeutics. In addition to that, Inozyme Pharma is 2.26 times more volatile than Century Therapeutics. It trades about -0.47 of its total potential returns per unit of risk. Century Therapeutics is currently generating about -0.15 per unit of volatility. If you would invest 102.00 in Century Therapeutics on October 22, 2024 and sell it today you would lose (11.10) from holding Century Therapeutics or give up 10.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Century Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Century Therapeutics |
Inozyme Pharma and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Century Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |